View Future GrowthIMAGIS 과거 순이익 실적과거 기준 점검 0/6지난 몇 년간 IMAGIS 의 실적에 대한 데이터가 부족합니다.핵심 정보n/a순이익 성장률n/a주당순이익(EPS) 성장률Semiconductor 산업 성장률23.50%매출 성장률n/a자기자본이익률n/a순이익률n/a최근 순이익 업데이트31 Dec 2019최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updatesNew Risk • Jun 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₩14.9b (US$9.67m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Shareholders have been substantially diluted in the past year (36% increase in shares outstanding). Market cap is less than US$10m (₩14.9b market cap, or US$9.67m). Minor Risk Share price has been volatile over the past 3 months (16% average weekly change).Board Change • Apr 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.공고 • Feb 13IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2026IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 105, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South KoreaNew Risk • Aug 26New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Market cap is less than US$100m (₩20.6b market cap, or US$14.8m).New Risk • Aug 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₩19.3b market cap, or US$14.0m).공고 • Aug 11IMAGIS Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 5.4054 billion.IMAGIS Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 5.4054 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 5,652,655 Price\Range: KRW 858 Security Name: Common Stock Security Type: Common Stock Securities Offered: 647,345 Price\Range: KRW 858 Transaction Features: Rights OfferingBoard Change • May 26Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.공고 • Apr 26IMAGIS Co., Ltd. announced that it has received KRW 999.999675 million in fundingOn April 25, 2025, IMAGIS Co., Ltd., closed the transaction.공고 • Apr 17IMAGIS Co., Ltd. announced that it expects to receive KRW 999.999675 million in fundingIMAGIS Co., Ltd. announces private placement to issue 687,285 Common Shares at a price of KRW 1,455 for gross proceeds of KRW 999,999,675 on April 17, 2025. Expected date of the closing is April 25, 2025.공고 • Feb 27815 Life & Health Co., Ltd. and others cancelled the acquisition of 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul.815 Life & Health Co., Ltd. and others agreed to acquire 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul for KRW 22.0 billion on December 12, 2024. A cash consideration valued at KRW 5432 per share will be paid by 815 Life & Health Co., Ltd. As part of consideration, an KRW 22 billion value is paid towards common equity of IMAGIS Co., Ltd. The expected completion of the transaction is March 25, 2025. As of January 24, 2025, the transaction closing date is expected on February 25, 2025. 815 Life & Health Co., Ltd. and others cancelled the acquisition of 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul on February 26, 2025. The cancellation occurred due to non-payment of the balance of the transfer company's stock sale.공고 • Feb 12IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2025IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 105, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South KoreaNew Risk • Nov 04New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩52.8b market cap, or US$38.5m).New Risk • Sep 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩39.6b market cap, or US$29.8m).New Risk • Aug 31New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩34.7b market cap, or US$26.0m).New Risk • Apr 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩48.7b market cap, or US$35.3m).New Risk • Jul 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Market cap is less than US$100m (₩41.5b market cap, or US$31.9m).Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.공고 • Feb 09IMAGIS Co., Ltd., Annual General Meeting, Mar 23, 2021IMAGIS Co., Ltd., Annual General Meeting, Mar 23, 2021, at 10:00 Korea Standard Time.Is New 90 Day High Low • Jan 29New 90-day low: ₩2,210The company is down 17% from its price of ₩2,650 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 46% over the same period.Is New 90 Day High Low • Nov 17New 90-day low: ₩2,485The company is down 14% from its price of ₩2,880 on 19 August 2020. The South Korean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 19% over the same period.Is New 90 Day High Low • Oct 30New 90-day low: ₩2,650The company is down 16% from its price of ₩3,145 on 31 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is down 3.0% over the same period.매출 및 비용 세부 내역IMAGIS가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSDAQ:A115610 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비31 Dec 1918,952-8,0176,5181,88830 Sep 1917,734-6,4177,53054830 Jun 1915,709-6,9037,32654831 Mar 1915,854-6,5087,26235731 Dec 1817,068-7,3787,3161,08330 Sep 1819,260-5,0475,2851,24230 Jun 1819,936-5,1855,7141,24231 Mar 1823,905-5,4516,2201,19731 Dec 1727,619-5,1116,55689330 Sep 1732,901-3,3465,3431,25530 Jun 1738,163-1,8755,2691,25531 Mar 1741,994-3784,8521,46831 Dec 1645,0359284,5141,86430 Sep 1644,1201,1464,6111,92330 Jun 1648,3842,1154,4321,92331 Mar 1646,7848714,9861,63331 Dec 1549,3481,4495,0471,32830 Sep 1550,1061,5845,5541,269양질의 수익: A115610가 고품질 수익을 갖고 있는지 판단하기에는 데이터가 부족합니다.이익 마진 증가: 지난 1년 동안 A115610의 이익률이 개선되었는지 판단하기에 데이터가 부족합니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 지난 5년 동안 A115610의 연간 수익 성장률이 양(+)이었는지 판단하기에 데이터가 부족합니다.성장 가속화: A115610의 지난해 수익 성장률을 5년 평균과 비교하기에 데이터가 부족합니다.수익 대 산업: A115610의 지난 해 수익 증가율이 Semiconductor 업계 평균을 상회했는지 판단하기에 데이터가 부족합니다.자기자본이익률높은 ROE: A115610는 현재 수익성이 없으므로 자본 수익률이 음수(0%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YSemiconductors 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/20 15:40종가2026/07/20 00:00수익2019/12/31연간 수익2019/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스IMAGIS Co., Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
New Risk • Jun 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₩14.9b (US$9.67m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Shareholders have been substantially diluted in the past year (36% increase in shares outstanding). Market cap is less than US$10m (₩14.9b market cap, or US$9.67m). Minor Risk Share price has been volatile over the past 3 months (16% average weekly change).
Board Change • Apr 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
공고 • Feb 13IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2026IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 105, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South Korea
New Risk • Aug 26New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Market cap is less than US$100m (₩20.6b market cap, or US$14.8m).
New Risk • Aug 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₩19.3b market cap, or US$14.0m).
공고 • Aug 11IMAGIS Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 5.4054 billion.IMAGIS Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 5.4054 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 5,652,655 Price\Range: KRW 858 Security Name: Common Stock Security Type: Common Stock Securities Offered: 647,345 Price\Range: KRW 858 Transaction Features: Rights Offering
Board Change • May 26Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
공고 • Apr 26IMAGIS Co., Ltd. announced that it has received KRW 999.999675 million in fundingOn April 25, 2025, IMAGIS Co., Ltd., closed the transaction.
공고 • Apr 17IMAGIS Co., Ltd. announced that it expects to receive KRW 999.999675 million in fundingIMAGIS Co., Ltd. announces private placement to issue 687,285 Common Shares at a price of KRW 1,455 for gross proceeds of KRW 999,999,675 on April 17, 2025. Expected date of the closing is April 25, 2025.
공고 • Feb 27815 Life & Health Co., Ltd. and others cancelled the acquisition of 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul.815 Life & Health Co., Ltd. and others agreed to acquire 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul for KRW 22.0 billion on December 12, 2024. A cash consideration valued at KRW 5432 per share will be paid by 815 Life & Health Co., Ltd. As part of consideration, an KRW 22 billion value is paid towards common equity of IMAGIS Co., Ltd. The expected completion of the transaction is March 25, 2025. As of January 24, 2025, the transaction closing date is expected on February 25, 2025. 815 Life & Health Co., Ltd. and others cancelled the acquisition of 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul on February 26, 2025. The cancellation occurred due to non-payment of the balance of the transfer company's stock sale.
공고 • Feb 12IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2025IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 105, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South Korea
New Risk • Nov 04New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩52.8b market cap, or US$38.5m).
New Risk • Sep 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩39.6b market cap, or US$29.8m).
New Risk • Aug 31New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩34.7b market cap, or US$26.0m).
New Risk • Apr 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩48.7b market cap, or US$35.3m).
New Risk • Jul 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Market cap is less than US$100m (₩41.5b market cap, or US$31.9m).
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
공고 • Feb 09IMAGIS Co., Ltd., Annual General Meeting, Mar 23, 2021IMAGIS Co., Ltd., Annual General Meeting, Mar 23, 2021, at 10:00 Korea Standard Time.
Is New 90 Day High Low • Jan 29New 90-day low: ₩2,210The company is down 17% from its price of ₩2,650 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 46% over the same period.
Is New 90 Day High Low • Nov 17New 90-day low: ₩2,485The company is down 14% from its price of ₩2,880 on 19 August 2020. The South Korean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 19% over the same period.
Is New 90 Day High Low • Oct 30New 90-day low: ₩2,650The company is down 16% from its price of ₩3,145 on 31 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is down 3.0% over the same period.